Circulating Tumor Microemboli Diagnostics for Patients with Non-Small Cell Lung Cancer

INTRODUCTION: Circulating Tumor Microemboli (CTM) are potentially important cancer biomarkers, but using them for cancer detection in early stage disease has been assay limited. We examined CTM test performance using a sensitive detection platform to identify stage I Non-Small Cell Lung Cancer (NSCL...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Carlsson, Anders, Nair, Viswam S., Luttgen, Madelyn S., Keu, Khun Visith, Horng, George, Vasanawala, Minal, Kolatkar, Anand, Jamali, Mehran, Iagaru, Andrei H., Kuschner, Ware, Loo, Billy W., Shrager, Joseph B., Bethel, Kelly, Hoh, Carl K., Bazhenova, Lyudmila, Nieva, Jorge, Kuhn, Peter, Gambhir, Sanjiv S.
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4145608/
https://ncbi.nlm.nih.gov/pubmed/25157764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0000000000000235
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items